NTR Company Profile and Key Details

The stock is currently mid-range between its 52-week high and low $53.03 and $85.36. With a market capitalization of about $32.12 billion, Nutrien Ltd. is classified as a large-cap and shows market-like volatility (beta ~1.06). Key stats such as the average daily volume over the past year has been around 2.78 million shares, in line with its 52-week average. Headquartered in Saskatoon, SK, Nutrien Ltd. operates in the Basic Materials sector and the Agricultural Inputs industry. Led by CEO Kenneth A. Seitz, the company employs approximately 25,500 people and listed since January 02, 2018. Nutrien Ltd., a company established in 2017 and based in Saskatoon, Canada, functions as a principal supplier of essential agricultural resources and associated services.

NTR has shown sold momentum, gaining 13.28% over the past week and 17.07% over the past quarter, though year-to-date performance is up 8.91%. Short-term trend indicators are bearishly aligned (SMA20 3.28%, SMA50 9.5%, SMA200 20.78%). The stock’s 14-day RSI is 61.93 (firm momentum), while the ATR of 1.98 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -0.57% below its high and over 59.74% above its low. Average 10-day trading volume of 2.46 million shares is in line with the 3-month average of 2.61 million, indicating normal recent market interest.

Nutrien Ltd. trades at a P/E ratio of 13.59, slightly below the S&P 500 average, with a price-to-sales ratio of 1.15 and a price-to-book ratio of 1.27 suggesting the stock is closer to book value. The P/FCF stands at 14.38, also above market averages.

Nutrien Ltd. last paid a dividend of 2.19 per share, this equals a trailing yield of roughly 3.76%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $58.00. This means the shares are trading above this model’s fair value.

Nutrien Ltd. generated EPS of $4.66 over the past year. Five-year average earnings growth is 42.06%. Wall Street analysts project EPS growth of 2.17% annually over the next five years. The latest quarter delivered EPS of $0.51. The next quarter is forecast at $0.52. Next year's EPS is expected at $2.92. Analyst sentiment is neutral. Analyst rating data shows there are 18 Strong Buy ratings, 2 Buy ratings, 22 Hold ratings, 2 Sell rating and 0 Strong Sell ratings. Price targets range from $100.00 to $58.00. The high target offers 49.43% upside. The low target suggests -13.33% downside. The mean target is $75.25. This offers 12.45% upside. Nutrien Ltd. earnings surprise history is a mixed track record. The quarter that ended May 06, 2026, missed forecasts by 6.25%. The prior quarter beat by -4.6%. Over the last six quarters, Apple has recorded several small beats. These include -16.22% in February 19, 2025.

Nutrien Ltd. has 480.02 million shares outstanding. The public float is 479.30 million shares, elevated short interest at 1.16% of float. This equals 5.57 million shares. The short ratio is 1.85 days. Institutional investors hold 71.99% of the float. Insiders own 0.03%. Fierro Joseph V holds 920.68 thousand shares, Akre David A has 102.40 thousand shares and Sherman Jerome F has 25.31 thousand shares.

Our AI price prediction model suggests that Nutrien Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.57%, with price expected at $68.64 by August 19, 2026, within a range of $67.04 to $70.52 3-Month Outlook: Projected rise of 24.57%, reaching $83.36 by November 02, 2026, with a range of $80.87 to $85.99. 1-Year Outlook: Projected gain of 5.69%, with price at $70.73 by August 05, 2027, within a range of $68.60 to $73.50.

Nutrien Ltd. (NYSE:NTR) shares are flat 8.91% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Nutrien Ltd. trading at a premium to the broader market with a P/E of 13.59. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $73.94, suggesting 10.49% upside. Our AI forecast model points to short-term strength (2.57% over two weeks), a medium-term rise (24.57% over three months), and a longer-term gain (5.69% over one year), with expected trading ranges indicating moderate volatility.